本页面由Tiger Trade Technology Pte. Ltd.提供服务

ICU医疗

163.91
+3.592.24%
成交量:20.14万
成交额:3,284.32万
市值:40.97亿
市盈率:136.17
高:164.40
开:159.73
低:159.50
收:160.32
52周最高:192.85
52周最低:113.37
股本:2,499.24万
流通股本:2,451.32万
量比:0.98
换手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):1.20
每股收益(LYR):0.0297
净资产收益率:1.41%
总资产收益率:1.93%
市净率:1.90
市盈率(LYR):5,517.55

数据加载中...

2024/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/16

重要事件披露

Form 8-K - Current report
2024/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/15

SEC问询函

Form CORRESP - Correspondence
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities